Minimally invasive coronary artery bypass grafting: a systematic review

Keita Kikuchi1, Makoto Mori2

  • 11 Department of Cardiac Surgery, Wuhan Asia Heart Hospital, Wuhan, China.

Insights

Minimally invasive coronary artery bypass grafting using bilateral internal thoracic arteries offers advantages over traditional methods. This technique expands surgical options for multi-arterial revascularization in cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery

Background:

  • Minimally invasive cardiac surgery (MICS) is increasingly adopted to reduce surgical morbidity.
  • Conventional coronary artery bypass grafting (CABG) and minimally invasive direct coronary artery bypass (MIDCAB) have limitations.

Purpose of the Study:

  • To review the evidence supporting off-pump coronary artery bypass (OPCAB) with bilateral internal thoracic artery (BITA) grafting in MICS.
  • To identify patient populations benefiting from BITA-MICS CABG and discuss surgical techniques and outcomes.

Main Methods:

  • Review of current evidence on OPCAB, multi-arterial revascularization, and BITA-MICS CABG.
  • Focus on surgical technique, patient selection, and early outcomes.

Main Results:

  • BITA grafting via small thoracotomy is feasible in a completely off-pump setting.
  • This technique overcomes previous limitations of BITA utilization in MICS.

Conclusions:

  • BITA-MICS CABG expands the surgical armamentarium for treating coronary artery disease.
  • Hybrid coronary revascularization incorporating BITA-MICS CABG represents the next generation of minimally invasive cardiac surgery.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
185
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
173
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
196